BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/03/2017

FDA Corrects Notice on Patient-Focused Drug Development for Sarcopenia Meeting

The FDA is updating the location of a public meeting on patient-focused drug development for sarcopenia, originally announced in the Federal Register on December 14, 2016, and is seeking public comment on the corrected notice.

Source: Federal Register — Food and Drug AdministrationOpen original release →